These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22003377)

  • 1. Viruses - from pathogens to vaccine carriers.
    Small JC; Ertl HC
    Curr Opin Virol; 2011 Oct; 1(4):241-5. PubMed ID: 22003377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A focus on vaccination strategies.
    Woodland DL
    Viral Immunol; 2014 Nov; 27(9):421. PubMed ID: 25361209
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant viruses as vaccines against viral diseases.
    Souza AP; Haut L; Reyes-Sandoval A; Pinto AR
    Braz J Med Biol Res; 2005 Apr; 38(4):509-22. PubMed ID: 15962176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines: developing new strategies to enhance immune responses.
    Abdulhaqq SA; Weiner DB
    Immunol Res; 2008; 42(1-3):219-32. PubMed ID: 19066740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel viral vectors in infectious diseases.
    Humphreys IR; Sebastian S
    Immunology; 2018 Jan; 153(1):1-9. PubMed ID: 28869761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challenges.
    Rappuoli R; Sutter G
    Curr Opin Virol; 2017 Apr; 23():vi-viii. PubMed ID: 28622999
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial overview.
    Ertl H; Pulendran B
    Curr Opin Virol; 2011 Oct; 1(4):223-5. PubMed ID: 22440780
    [No Abstract]   [Full Text] [Related]  

  • 8. New viral vectors for infectious diseases and cancer.
    Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
    Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.
    Bowick GC; McAuley AJ
    Bioeng Bugs; 2011; 2(3):129-35. PubMed ID: 21637006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral vectors as vaccine platforms: deployment in sight.
    Rollier CS; Reyes-Sandoval A; Cottingham MG; Ewer K; Hill AV
    Curr Opin Immunol; 2011 Jun; 23(3):377-82. PubMed ID: 21514130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles-derived vaccines to prevent emerging viral diseases.
    Frantz PN; Teeravechyan S; Tangy F
    Microbes Infect; 2018; 20(9-10):493-500. PubMed ID: 29410084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal vaccination and the evolution of viral pathogens.
    Schat KA; Baranowski E
    Rev Sci Tech; 2007 Aug; 26(2):327-38. PubMed ID: 17892155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant viruses as tools to induce protective cellular immunity against infectious diseases.
    Rocha CD; Caetano BC; Machado AV; Bruna-Romero O
    Int Microbiol; 2004 Jun; 7(2):83-94. PubMed ID: 15248156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capripoxvirus-vectored vaccines against livestock diseases in Africa.
    Boshra H; Truong T; Nfon C; Gerdts V; Tikoo S; Babiuk LA; Kara P; Mather A; Wallace D; Babiuk S
    Antiviral Res; 2013 May; 98(2):217-27. PubMed ID: 23499648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Amplifying RNA Viruses as RNA Vaccines.
    Lundstrom K
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines and viral antigenic diversity.
    Mumford JA
    Rev Sci Tech; 2007 Apr; 26(1):69-90. PubMed ID: 17633294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination.
    Breathnach CC; Rudersdorf R; Lunn DP
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):127-36. PubMed ID: 15010222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines.
    Mok DZL; Chan KR
    Viruses; 2020 May; 12(5):. PubMed ID: 32397218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavivirus DNA Vaccine Design and Adjuvant Selection.
    Li L; Honda-Okubo Y; Petrovsky N
    Methods Mol Biol; 2021; 2183():405-422. PubMed ID: 32959256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of gene-based vaccines.
    Barouch DH
    J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.